Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Change in Account Payables (2016 - 2025)

Lipocine's Change in Account Payables history spans 13 years, with the latest figure at $418458.0 for Q3 2025.

  • For Q3 2025, Change in Account Payables rose 356.01% year-over-year to $418458.0; the TTM value through Sep 2025 reached $576105.0, up 170.63%, while the annual FY2024 figure was -$1.1 million, 241.31% down from the prior year.
  • Change in Account Payables reached $418458.0 in Q3 2025 per LPCN's latest filing, up from $82755.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $583481.0 in Q3 2023 to a low of -$1.0 million in Q1 2021.
  • Average Change in Account Payables over 5 years is -$38724.6, with a median of -$13651.0 recorded in 2024.
  • Peak YoY movement for Change in Account Payables: soared 1080.81% in 2023, then plummeted 469.49% in 2024.
  • A 5-year view of Change in Account Payables shows it stood at $563790.0 in 2021, then crashed by 105.33% to -$30068.0 in 2022, then skyrocketed by 1080.81% to $294909.0 in 2023, then tumbled by 104.63% to -$13651.0 in 2024, then skyrocketed by 3165.4% to $418458.0 in 2025.
  • Per Business Quant, the three most recent readings for LPCN's Change in Account Payables are $418458.0 (Q3 2025), $82755.0 (Q2 2025), and $88543.0 (Q1 2025).